Chronic Migraine Epidemiology and Outcomes Study
|ClinicalTrials.gov Identifier: NCT01648530|
Recruitment Status : Completed
First Posted : July 24, 2012
Results First Posted : January 29, 2015
Last Update Posted : January 29, 2015
|Condition or disease||Intervention/treatment|
|Migraine Disorders||Other: No Treatment|
|Study Type :||Observational|
|Actual Enrollment :||16789 participants|
|Study Start Date :||July 2012|
|Primary Completion Date :||November 2013|
|Study Completion Date :||November 2013|
Participants with Migraines
Participants who returned completed internet survey with positive screening for migraines. No intervention was administered in this study.
Other: No Treatment
- Percentage of Participants With Episodic Migraine (EM) or Chronic Migraine (CM) [ Time Frame: Baseline ]EM is defined as <15 headache days/month and CM is defined as ≥15 headache days/month.
- Migraine Disability Assessment (MIDAS) [ Time Frame: 12 Months ]The Midas score is a patient completed 5-item questionnaire about lost time and productivity (for work, school or family/social activities) in the past 3 months (number of days missed) where: 0-5=Little or No disability, 6-10=Mild disability, 11-20=Moderate disability or 21+ Severe disability. The Midas scores assessed at Months 3, 6, 9 and 12 were averaged.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01648530
|Study Director:||Medical Director||Allergan|